Circulating biomarkers improve prediction of postoperative outcome after aortic valve surgery - Report - MDSpire

Circulating biomarkers improve prediction of postoperative outcome after aortic valve surgery

  • By

  • Till Joscha Demal

  • Jenny Bialczak

  • Alina Goßling

  • Francisco Miguel Ojeda

  • Oliver Daniel Bhadra

  • Björn Sill

  • Johannes Petersen

  • Sebastian Ludwig

  • David Grundmann

  • Lisa Voigtländer

  • Lara Waldschmidt

  • Laura Hannen

  • Niklas Schofer

  • Stefan Blankenberg

  • Paulus Kirchhof

  • Thomas Renné

  • Lenard Conradi

  • Hermann Reichenspurner

  • Evaldas Girdauskas

  • Andreas Schaefer

  • June 2, 2026

  • 0 min

Share

Clinical Report: Preoperative Circulating Biomarkers Enhance Prediction of Postoperative Outcomes Following Aortic Valve Surgery

Overview

This study investigates the association between preoperative circulating biomarkers and postoperative outcomes in patients undergoing aortic valve surgery.

Background

Predicting postoperative complications following aortic valve surgery is critical for patient management and decision-making. Current risk stratification tools, such as EuroSCORE-II, may not fully capture the complexity of individual patient risks. The integration of preoperative biomarkers could enhance the predictive capabilities of these models.

Data Highlights

BiomarkerOdds Ratio (OR)95% Confidence Interval (CI)p-value
Hemoglobin0.700.57, 0.87<0.001
Creatinine4.091.63, 10.260.003
hsTrop-I1.481.11, 1.950.007
GOT2.491.06, 5.860.036
INR4.741.32, 17.050.017
CRP2.141.53, 3.00<0.001
NT-proBNP2.061.41, 3.00<0.001
WBC5.821.88, 17.970.002

Key Findings

  • Preoperative hemoglobin levels were inversely associated with 30-day mortality.
  • Higher creatinine levels were linked to increased odds of postoperative mortality.
  • High-sensitivity troponin I levels showed a positive correlation with adverse outcomes.
  • Combining biomarkers with EuroSCORE-II improved predictive performance for mortality.

Clinical Implications

The findings suggest that preoperative biomarker assessment can enhance risk stratification for patients undergoing aortic valve surgery. Clinicians may consider integrating these biomarkers into decision-making processes to better predict postoperative outcomes.

Conclusion

The study demonstrates the association between preoperative circulating biomarkers and postoperative outcomes following aortic valve surgery.

Related Resources & Content

  1. Clinical Research in Cardiology, 2025 -- EASIX as a Prognostic Indicator for Three-Year Mortality in Patients with Aortic Stenosis Undergoing TAVR
  2. Clinical Research in Cardiology, 2024 -- Evaluating the Prognostic Value of Mid-Regional Pro-Adrenomedullin and Growth Differentiation Factor 15 in Patients Undergoing Transfemoral Transcatheter Aortic Valve Replacement
  3. Clinical Research in Cardiology, 2023 -- Prognostic Significance and Diagnostic Utility of Invasively Obtained Hemodynamic Metrics in Severe Aortic Stenosis Patients Undergoing Transcatheter Aortic Valve Implantation
  4. Clinical Research in Cardiology, 2025 -- Assessment of Patient Risk Factors for Transcatheter Aortic Valve Replacement (PRE-TAVR)
  5. 2025 ESC/EACTS Guidelines for the management of valvular heart disease
  6. 2025 ESC/EACTS Guidelines for the management of valvular heart disease
  7. Prognostic Implications of Preoperative N-Terminal Pro-B-Type Natriuretic Peptide Dynamics in Patients Undergoing Cardiac Surgery - PMC
  8. The prognostic utility of galectin-3 in patients undergoing cardiac surgery: a scoping review: Biomarkers: Vol 29, No 7

Original Source(s)

Related Content